Knockdown of arginase I restores NO signaling in the vasculature of old rats - PubMed (original) (raw)
Knockdown of arginase I restores NO signaling in the vasculature of old rats
Anthony R White et al. Hypertension. 2006 Feb.
Abstract
Arginase, expressed in endothelial cells and upregulated in aging blood vessels, competes with NO synthase (NOS) for l-arginine, thus modulating vasoreactivity and attenuating NO signaling. Moreover, arginase inhibition restores endothelial NOS signaling and l-arginine responsiveness in old rat aorta. The arginase isoform responsible for modulating NOS, however, remains unknown. Because isoform-specific arginase inhibitors are unavailable, we used an antisense (AS) oligonucleotide approach to knockdown arginase I (Arg I). Western blot and quantitative PCR confirmed that Arg I is the predominant isoform expressed in endothelialized aortic rings and is upregulated in old rats compared with young. Aortic rings from 22-month-old rats were incubated for 24 hours with sense (S), AS oligonucleotides, or medium alone (C). Immunohistochemistry, immunoblotting, and enzyme assay confirmed a significant knockdown of Arg I protein and arginase activity in AS but not S or C rings. Conversely, calcium-dependent NOS activity and vascular metabolites of NO was increased in AS versus S or C rings. Acetylcholine (endothelial-dependent) vasorelaxant responses were enhanced in AS versus S or C treated rings. In addition, 1H-oxadiazolo quinoxalin-1-one (10 micromol/L), a soluble guanylyl cyclase inhibitor, increased the phenylephrine response in AS compared with S and C rings suggesting increased NO bioavailability. Finally, l-arginine (0.1 mmol/L)-induced relaxation was increased in AS versus C rings. These data support our hypothesis that Arg I plays a critical role in the pathobiology of age-related endothelial dysfunction. AS oligonucleotides may, therefore, represent a novel therapeutic strategy against age-related vascular endothelial dysfunction.
Comment in
- Does arginase activity in vitro represent that in vivo?
Zhang WZ, Kaye DM. Zhang WZ, et al. Hypertension. 2006 Oct;48(4):E14; author reply E15. doi: 10.1161/01.HYP.0000240637.91493.f5. Epub 2006 Aug 28. Hypertension. 2006. PMID: 16940210 No abstract available.
Similar articles
- Arginase reciprocally regulates nitric oxide synthase activity and contributes to endothelial dysfunction in aging blood vessels.
Berkowitz DE, White R, Li D, Minhas KM, Cernetich A, Kim S, Burke S, Shoukas AA, Nyhan D, Champion HC, Hare JM. Berkowitz DE, et al. Circulation. 2003 Oct 21;108(16):2000-6. doi: 10.1161/01.CIR.0000092948.04444.C7. Epub 2003 Sep 29. Circulation. 2003. PMID: 14517171 - Endothelial dysfunction in rat adjuvant-induced arthritis: up-regulation of the vascular arginase pathway.
Prati C, Berthelot A, Wendling D, Demougeot C. Prati C, et al. Arthritis Rheum. 2011 Aug;63(8):2309-17. doi: 10.1002/art.30391. Arthritis Rheum. 2011. PMID: 21484767 - Mitochondrial arginase II constrains endothelial NOS-3 activity.
Lim HK, Lim HK, Ryoo S, Benjo A, Shuleri K, Miriel V, Baraban E, Camara A, Soucy K, Nyhan D, Shoukas A, Berkowitz DE. Lim HK, et al. Am J Physiol Heart Circ Physiol. 2007 Dec;293(6):H3317-24. doi: 10.1152/ajpheart.00700.2007. Epub 2007 Sep 7. Am J Physiol Heart Circ Physiol. 2007. PMID: 17827260 - Arginase and vascular aging.
Santhanam L, Christianson DW, Nyhan D, Berkowitz DE. Santhanam L, et al. J Appl Physiol (1985). 2008 Nov;105(5):1632-42. doi: 10.1152/japplphysiol.90627.2008. Epub 2008 Aug 21. J Appl Physiol (1985). 2008. PMID: 18719233 Free PMC article. Review. - Phenolic Compounds as Arginase Inhibitors: New Insights Regarding Endothelial Dysfunction Treatment.
Minozzo BR, Fernandes D, Beltrame FL. Minozzo BR, et al. Planta Med. 2018 Mar;84(5):277-295. doi: 10.1055/s-0044-100398. Epub 2018 Jan 17. Planta Med. 2018. PMID: 29342480 Review.
Cited by
- Arginase: an old enzyme with new tricks.
Caldwell RB, Toque HA, Narayanan SP, Caldwell RW. Caldwell RB, et al. Trends Pharmacol Sci. 2015 Jun;36(6):395-405. doi: 10.1016/j.tips.2015.03.006. Epub 2015 Apr 27. Trends Pharmacol Sci. 2015. PMID: 25930708 Free PMC article. Review. - Chronic oral administration of the arginase inhibitor 2(S)-amino-6-boronohexanoic acid (ABH) improves erectile function in aged rats.
Segal R, Hannan JL, Liu X, Kutlu O, Burnett AL, Champion HC, Kim JH, Steppan J, Berkowitz DE, Bivalacqua TJ. Segal R, et al. J Androl. 2012 Nov-Dec;33(6):1169-75. doi: 10.2164/jandrol.111.015834. Epub 2012 Apr 5. J Androl. 2012. PMID: 22492840 Free PMC article. - Genetic Deletion of ACE2 Induces Vascular Dysfunction in C57BL/6 Mice: Role of Nitric Oxide Imbalance and Oxidative Stress.
Rabelo LA, Todiras M, Nunes-Souza V, Qadri F, Szijártó IA, Gollasch M, Penninger JM, Bader M, Santos RA, Alenina N. Rabelo LA, et al. PLoS One. 2016 Apr 12;11(4):e0150255. doi: 10.1371/journal.pone.0150255. eCollection 2016. PLoS One. 2016. PMID: 27070147 Free PMC article. - Pathophysiology of Arginases in Cancer and Efforts in Their Pharmacological Inhibition.
Marzęta-Assas P, Jacenik D, Zasłona Z. Marzęta-Assas P, et al. Int J Mol Sci. 2024 Sep 10;25(18):9782. doi: 10.3390/ijms25189782. Int J Mol Sci. 2024. PMID: 39337272 Free PMC article. Review. - Urinary excretion of asymmetric (ADMA) and symmetric (SDMA) dimethylarginine is positively related to nitric oxide level in tissues of normotensive and hypertensive rats.
Szlęzak D, Ufnal M, Drapała A, Samborowska E, Wróbel M. Szlęzak D, et al. Amino Acids. 2023 Apr;55(4):529-539. doi: 10.1007/s00726-023-03246-9. Epub 2023 Feb 19. Amino Acids. 2023. PMID: 36802034 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Research Materials